<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Stocks on FinanClub</title>
    <link>https://finan.club/tags/stocks/</link>
    <description>Recent content in Stocks on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 18 Mar 2024 09:04:03 +0000</lastBuildDate><atom:link href="https://finan.club/tags/stocks/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>SWN</title>
      <link>https://finan.club/us/swn/</link>
      <pubDate>Mon, 18 Mar 2024 09:04:03 +0000</pubDate>
      
      <guid>https://finan.club/us/swn/</guid>
      <description>score:190
Chances: Higher institutional ownership indicates stock price sensitivity Higher oil production and reduction in marketing purchases positively impact earnings Bull case for natural gas rests on expanding U.S. exports Earnings and revenue surprises indicate potential for stock growth SWN announces strong cash flow despite lower commodity prices Front-month gas futures rise due to supply and demand factors Chesapeake Energy delivers positive earnings and revenue surprises Risks: Stock price sensitive to broader macroeconomic environment Daily output drop in gas production may impact future earnings Commodity prices may continue to fluctuate Earnings beat expectations but may not be sustained in future quarters Market conditions may impact sales and revenue Score:190 chances characters count - risks characters count = 190</description>
    </item>
    
    <item>
      <title>PLTR</title>
      <link>https://finan.club/us/pltr/</link>
      <pubDate>Mon, 18 Mar 2024 09:03:14 +0000</pubDate>
      
      <guid>https://finan.club/us/pltr/</guid>
      <description>score:-34
Chances: Palantir is becoming widely adopted by large enterprises building out AI platforms. Palantir&amp;rsquo;s unique approach to customer acquisition is paying off in spades. Palantir&amp;rsquo;s AI prowess is years in the making. The data analytics powerhouse is up substantially in 2024 thanks to the growing adoption of AI.</description>
    </item>
    
    <item>
      <title>ET</title>
      <link>https://finan.club/us/et/</link>
      <pubDate>Thu, 29 Feb 2024 09:03:23 +0000</pubDate>
      
      <guid>https://finan.club/us/et/</guid>
      <description>score:-33
Chances: ET engages in natural gas pipeline transportation and transmission services Higher oil production and reduction in marketing purchases aid Q4 earnings The average brokerage recommendation for ET is equivalent to a Buy Investors may keep a tab on stocks like ET that have higher dividend yields compared to the industry Risks: Effectiveness of overly optimistic recommendations of Wall Street analysts is questionable Lower commodity price realizations affecting Q4 earnings Potential challenges in finding the right dividend stocks to invest in The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable Score:-33 chances characters count - risks characters count = -33</description>
    </item>
    
    <item>
      <title>APP</title>
      <link>https://finan.club/us/app/</link>
      <pubDate>Wed, 24 Jan 2024 09:04:31 +0000</pubDate>
      
      <guid>https://finan.club/us/app/</guid>
      <description>score:-63
Chances: AppLovin has been hot, and the run higher might have some momentum. AppLovin (APP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company&amp;rsquo;s earnings prospects. Risks: It&amp;rsquo;s always important to assess the risk involved in investing in a company, especially in the volatile tech sector.</description>
    </item>
    
    <item>
      <title>AZN</title>
      <link>https://finan.club/us/azn/</link>
      <pubDate>Tue, 19 Dec 2023 09:06:54 +0000</pubDate>
      
      <guid>https://finan.club/us/azn/</guid>
      <description>score:-135
Chances: AstraZeneca (AZN) closed at $65.95, indicating a +1.77% shift from the previous trading day. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax. The additional supply of RSV shot for infants by AstraZeneca and Sanofi indicates a positive outlook for meeting winter demand.</description>
    </item>
    
  </channel>
</rss>
